Treatment-resistant posttraumatic stress disorder

• Psychedelics, entactogens and psychoplastogens for depression and related disorders
• The pattern of dissociative symptoms differs between post-traumatic stress disorder and first esketamine administration for treatment-resistant depression
• Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework
• Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa
• Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
• Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model
• Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depression
• Effects of ketamine on fear memory extinction: a review of preclinical literature

Treatment-resistant posttraumatic stress disorder (PTSD) refers to a condition in which individuals diagnosed with PTSD do not respond adequately to standard or evidence-based posttraumatic stress disorder treatments.

see Posttraumatic stress disorder in Neurosurgery